Gilead & Remdesivir mentioned by a guest analyst o
Post# of 72440
(Total Views: 515)
Posted On: 04/22/2021 11:17:57 AM
Gilead & Remdesivir mentioned by a guest analyst on Fox Business just minutes ago. What was mentioned? 25 BILLION of cash on hand, interest in acquiring promising biotech properties, and issues with Remdesivir. I bet they aren't watching any active drug trials. That would be such a waste of time for them because they can just wait for "the market" to guide their business decisions.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼